Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Accumulated Expenses (2021 - 2025)

Coeptis Therapeutics Holdings has reported Accumulated Expenses over the past 5 years, most recently at $41054.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $41054.0 for Q4 2025, down 94.43% from a year ago — trailing twelve months through Dec 2025 was $41054.0 (down 94.43% YoY), and the annual figure for FY2025 was $41054.0, down 94.43%.
  • Accumulated Expenses for Q4 2025 was $41054.0 at Coeptis Therapeutics Holdings, down from $210892.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for COEPW hit a ceiling of $771035.0 in Q2 2024 and a floor of $41054.0 in Q4 2025.
  • Median Accumulated Expenses over the past 5 years was $491235.0 (2023), compared with a mean of $461787.6.
  • Biggest five-year swings in Accumulated Expenses: soared 205.47% in 2023 and later plummeted 94.43% in 2025.
  • Coeptis Therapeutics Holdings' Accumulated Expenses stood at $199126.0 in 2021, then dropped by 8.6% to $181998.0 in 2022, then soared by 205.47% to $555950.0 in 2023, then surged by 32.55% to $736884.0 in 2024, then plummeted by 94.43% to $41054.0 in 2025.
  • The last three reported values for Accumulated Expenses were $41054.0 (Q4 2025), $210892.0 (Q3 2025), and $416209.0 (Q2 2025) per Business Quant data.